ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Scheme : NHMRC Project Grants
Research Topic : Toxicity
Clear All
Filter by Field of Research
Medical biochemistry - inorganic elements and compounds (5)
Medical biochemistry - lipids (4)
Biochemistry And Cell Biology Not Elsewhere Classified (2)
Endocrinology (2)
Medical biochemistry - carbohydrates (2)
Pharmacology and Pharmaceutical Sciences (2)
Allergy (1)
Biophysics (1)
Clinical Pharmacology and Therapeutics (1)
Clinical Sciences (1)
Clinical chemistry (incl. diagnostics) (1)
Clinical sciences not elsewhere classified (1)
Geriatrics And Gerontology (1)
Haematology (1)
Immunogenetics (incl. Genetic Immunology) (1)
Infectious Diseases (1)
Medical Bacteriology (1)
Medical Parasitology (1)
Medical and Health Sciences (1)
Medical infection agents (incl. prions) (1)
Medical virology (1)
Nanotoxicology, Health and Safety (1)
Neurology And Neuromuscular Diseases (1)
Nutrigenomics and personalised nutrition (1)
Nutrition and dietetics not elsewhere classified (1)
Oncology and Carcinogenesis not elsewhere classified (1)
Opthalmology And Vision Science (1)
Oral and maxillofacial surgery (1)
Orthopaedics (1)
Radiation Therapy (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (50)
Filter by Status
Closed (50)
Filter by Scheme
NHMRC Project Grants (50)
Filter by Country
Australia (4)
Filter by Australian State/Territory
VIC (2)
WA (2)
NSW (1)
SA (1)
  • Researchers (0)
  • Funded Activities (50)
  • Organisations (0)
  • Funded Activity

    Identification Of Cardiac Sarcoplasmic Reticulum Targets For Cardiotoxic Drugs

    Funder
    National Health and Medical Research Council
    Funding Amount
    $265,986.00
    Summary
    Anthracyclines are drugs which are used successfully in chemotherapy. Unfortunately, these drugs can lead to serious heart problems which sometimes result in death, and the mechanisms behind this remain elusive. Finding the specific targets of these drugs and how these drugs affect heart contraction may lead to designing drug cocktails which protect the heart from side effects.
    More information
    Funded Activity

    Effects Of Ageing On Hepatic Drug Clearance And Mechanisms Of Drug Induced Liver Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $581,892.00
    Summary
    With increasing age, there is increase in disease, for which medications may provide benefit, and an increase in the risk of adverse drug reactions, even after considering the increase in medication use by older people. We will investigate how the liver clears drugs from the blood in old age. This will guide dosing of medications for older people. We will also study how drugs injure the liver in old age and test interventions to prevent this toxicity.
    More information
    Funded Activity

    Research Into The Toxicity Of Traditional Chinese Medicines And Development Of A Toxicity Database For Austral

    Funder
    National Health and Medical Research Council
    Funding Amount
    $170,766.00
    More information
    Funded Activity

    Immunotoxic Effects Of Engineered Nanomaterials Used In The Australian Workplace

    Funder
    National Health and Medical Research Council
    Funding Amount
    $586,816.00
    Summary
    Certain engineered nanomaterials are more toxic than their bulk material forms. We urgently need the ability to re-engineer these nanomaterials to reduce their toxicity and potential health risks, but lack the necessary knowledge. This project directly addresses the NHMRC Strategic Initiative on Nanotechnology and Health, by providing essential information for designing safer nanomaterials from systemically studying the immune effects of metal oxide nanoparticles used in Australian industry.
    More information
    Funded Activity

    An Investigation Into Liver Damage Caused By Reactive C Hemicals

    Funder
    National Health and Medical Research Council
    Funding Amount
    $120,759.00
    More information
    Funded Activity

    The Toxicology Of Nanomaterials

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,907,006.00
    Summary
    This application will investigate the potential for nanomaterials to have adverse effects on human health and to formulate approaches to screen nanomaterials for potential health risks, particularly those with a high likelihood for human exposure in Australia. Understanding how existing nanomaterials interact with biological systems will help determine the risk of adverse effects in the human population and identify those nanoparticles with little or no risk.
    More information
    Funded Activity

    Oxygen Toxicity As A Factor In Retinal Degenerations: Genetic And Environmental Mechanisms

    Funder
    National Health and Medical Research Council
    Funding Amount
    $269,250.00
    Summary
    This project will explore the mechanisms underlying a group of blinding diseases called Retinitis Pigmentosa (RP). They are caused by the death or degneration of the light-receptive cells of the retina of the eye (photoreceptors). It is well established that many forms of RP are caused by genetic mutations but many cases (40-50%) occur 'sporadically', i.e. without a family history. Further there is growing evidence that the rate at which genetic forms of the disease progress is strongly influenc .... This project will explore the mechanisms underlying a group of blinding diseases called Retinitis Pigmentosa (RP). They are caused by the death or degneration of the light-receptive cells of the retina of the eye (photoreceptors). It is well established that many forms of RP are caused by genetic mutations but many cases (40-50%) occur 'sporadically', i.e. without a family history. Further there is growing evidence that the rate at which genetic forms of the disease progress is strongly influenced by environmental factors, particularly light and oxygen. To analyse how these environmental factors affect the stability of the retina, we will use a range of techniques (including gene array technology) to study the molecular events which link light or oxygen stress to photoreceptor death. The work will be done in mouse 'models' of the disease. It is increasingly well established that the rodent (rat and mouse) retina and human retina share a basic structure and functional detail. These models allow intensive investigation, with results which are directly applicable to human disease. Our principal emphasis will be on three aspects of these models: (1) the molecular mechanisms induced in the retina by light stress or oxygen stress; (2) the role of mitochondria (cellular organelles essential for both cell metabolism and cell stability; and (3) genes which regulate the vulnerability of photoreceptors to oxygen stress. RP has been recognised for nearly 100 years as a leading cause of blindness in young adults. It is usually diagnosed in the young adult as a failure of night vision, but the prognosis is grim (relentlessly progressive loss of vision), and there is still no effective treatment. The work proposed will contribute to our understanding of the basic mechanisms involved, and will explore some approaches to therapy for, or at least to mitigation of the blindness of RP.
    Read more Read less
    More information
    Funded Activity

    Targeted Delivery By Topical Application

    Funder
    National Health and Medical Research Council
    Funding Amount
    $631,052.00
    Summary
    Many products are applied to the skin to prevent skin cancer or to treat skin diseases. This project seeks to better understand how we can make such products more affective, safer and appropriate for conditions such as psoriasis. One major component of the grant is concerned with the evaluation of nanotechnology products applied to the skin.
    More information
    Funded Activity

    Cyclosporin A-induced Liver Injury

    Funder
    National Health and Medical Research Council
    Funding Amount
    $184,422.00
    More information
    Funded Activity

    Studies On The Cause Of Type 2 Diabetes

    Funder
    National Health and Medical Research Council
    Funding Amount
    $282,003.00
    More information

    Showing 1-10 of 50 Funded Activites

    • 1
    • 2
    • 3
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback